Why This Large Cap Stock Is Down After Buying Stake In Competitor

Shares of pharma major Ipca Laboratories tanked on Wednesday after the company completed buying a stake in rival Unichem Laboratories.

What Happened: Ipca said it successfully completed the acquisition, valued at ₹945.35 crore at ₹402.25 per share, which is at a premium of around 1% to Unichem’s last close.

The company said it has already made an open offer to public shareholders of Unichem as it looks to acquire up to 26% of Unichem Laboratories at a price of ₹440 per share, totaling ₹605.44 crore.

Price Action: Ipca’s share price was down nearly 1.55% at ₹888.40 in the afternoon on Wednesday.

Meanwhile, Unichem’s share price was down 0.45% at ₹396.50 late in the session.

Read Next: PayU Sets Sights On $6B Valuation for India IPO: Report

Don't miss a beat on the share market. Get real-time updates on top stock movers and trading ideas on Benzinga India Telegram channel.

Posted In: EquitiesM&AWIIMMarketsIPCAUnichem Laboratories